Advertisement

Cancer Causes & Control

, Volume 23, Issue 12, pp 1921–1927 | Cite as

The incidences of malignant gonadal and extragonadal germ cell tumors in males and females: a population-based study covering over 40 years in Finland

  • Satu-Liisa Pauniaho
  • Jonna Salonen
  • Mika Helminen
  • Kim Vettenranta
  • Markku Heikinheimo
  • Oskari Heikinheimo
Original paper

Abstract

Purpose

Germ cell tumors (GCTs) comprise a heterogeneous group of tumors derived from primordial germ cells. The incidence of malignant testicular GCTs has increased in recent decades, but little is known about possible changes in malignant female GCTs. Population-based data covering all malignant GCTs in both sexes remain limited.

Methods

All cases of malignant GCTs in 1969–2008 were collected from the Finnish Cancer Registry and their age-adjusted annual incidences calculated.

Results

The overall incidence of malignant GCTs was 2.56 per 100,000 person-years in males and 0.34 per 100,000 in females. The incidence of gonadal GCTs increased from 2.27 to 8.36 per 100,000 in males between 15 and 44 years of age. Moreover, the incidence of all histological subtypes of gonadal GCTs increased in males. In females, the only increase was seen in the incidence of ovarian non-dysgerminoma (from 0.07 to 0.29/100,000). The incidence of extragonadal GCTs did not change during the study period, being 0.18 and 0.10 per 100,000 in males and females, respectively.

Conclusions

The incidence of gonadal GCTs in males increased significantly during the 40-year study period, whereas in females, no such change was observed. There were significant gender differences regarding the distribution of histological subtypes and patients’ ages. However, the incidence of extragonadal GCTs remained low in both sexes. The differences in the incidences of gonadal GCTs derived from the same population suggest that the risk factors of these malignancies differ between the two sexes.

Keywords

Extragonadal germ cell tumor Germ cell tumor Incidence Malignant Ovary Testis 

Notes

Acknowledgments

We wish to thank Dr. Risto Sankila, M.D., Ph.D., from the Finnish Cancer Registry for his highly professional collaboration regarding cancer statistics. Financial support from the Sigrid Jusélius Foundation, the Nona and Kullervo Väre Foundation, Helsinki University Central Hospital Research Funds, the Pediatric Graduate School, University of Helsinki, and the National Graduate School of Clinical Investigation is gratefully acknowledged.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Schneider DT, Calaminus G, Koch S et al (2004) Epidemiologic analysis of 1,442 children and adolescents registered in the German germ cell tumor protocols. Pediatr Blood Cancer 42:169–175PubMedCrossRefGoogle Scholar
  2. 2.
    McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE (2003) Trends in the incidence of testicular germ cell tumors in the United States. Cancer 97:63–70PubMedCrossRefGoogle Scholar
  3. 3.
    Agnarsson BA, Gudbjartsson T, Einarsson GV et al (2006) Testicular germ cell tumours in Iceland: a nationwide clinicopathological study. APMIS 114:779–783PubMedCrossRefGoogle Scholar
  4. 4.
    Smith HO, Berwick M, Verschraegen CF et al (2006) Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol 107:1075–1085PubMedCrossRefGoogle Scholar
  5. 5.
    Arora RS, Alston RD, Eden TO, Geraci M, Birch JM (2012) Comparative incidence patterns and trends of gonadal and extragonadal germ cell tumors in England, 1979 to 2003. Cancer (Epub ahead of print)Google Scholar
  6. 6.
    Moller H, Evans H (2003) Epidemiology of gonadal germ cell cancer in males and females. APMIS 111:43–46 (discussion 46–8)Google Scholar
  7. 7.
    Stang A, Trabert B, Wentzensen N, et al. (2012) Gonadal and extragonadal germ cell tumours in the United States, 1973–2007. Int J Androl (Epub ahead of print)Google Scholar
  8. 8.
    Bosl GJ, Motzer RJ (1997) Testicular germ-cell cancer. N Engl J Med 337:242–253PubMedCrossRefGoogle Scholar
  9. 9.
    Huyghe E, Matsuda T, Thonneau P (2003) Increasing incidence of testicular cancer worldwide: a review. J Urol 170:5–11PubMedCrossRefGoogle Scholar
  10. 10.
    Schmiedel S, Schuz J, Skakkebaek NE, Johansen C (2010) Testicular germ cell cancer incidence in an immigration perspective, Denmark, 1978 to 2003. J Urol 183:1378–1382PubMedCrossRefGoogle Scholar
  11. 11.
    Richiardi L, Bellocco R, Adami HO et al (2004) Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 13:2157–2166PubMedGoogle Scholar
  12. 12.
    Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA (2010) International trends in the incidence of testicular cancer, 1973–2002. Cancer Epidemiol Biomarkers Prev 19:1151–1159PubMedCrossRefGoogle Scholar
  13. 13.
    Ioka A, Tsukuma H, Ajiki W, Oshima A (2003) Ovarian cancer incidence and survival by histologic type in Osaka, Japan. Cancer Sci 94:292–296PubMedCrossRefGoogle Scholar
  14. 14.
    Dieckmann KP, Pichlmeier U (2004) Clinical epidemiology of testicular germ cell tumors. World J Urol 22:2–14PubMedCrossRefGoogle Scholar
  15. 15.
    Skakkebaek NE, Rajpert-De Meyts E, Main KM (2001) Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 16:972–978PubMedCrossRefGoogle Scholar
  16. 16.
    Jorgensen N, Vierula M, Jacobsen R et al (2011) Recent adverse trends in semen quality and testis cancer incidence among Finnish men. Int J Androl 34:e37–e48PubMedCrossRefGoogle Scholar
  17. 17.
    McGlynn KA, Cook MB (2009) Etiologic factors in testicular germ-cell tumors. Future Oncol 5:1389–1402PubMedCrossRefGoogle Scholar
  18. 18.
    Wanderas EH, Grotmol T, Fossa SD, Tretli S (1998) Maternal health and pre- and perinatal characteristics in the etiology of testicular cancer: a prospective population- and register-based study on Norwegian males born between 1967 and 1995. Cancer Causes Control 9:475–486PubMedCrossRefGoogle Scholar
  19. 19.
    Gershman ST, Stolley PD (1988) A case-control study of testicular cancer using Connecticut tumour registry data. Int J Epidemiol 17:738–742PubMedCrossRefGoogle Scholar
  20. 20.
    Aschim EL, Haugen TB, Tretli S, Daltveit AK, Grotmol T (2006) Risk factors for testicular cancer—differences between pure non-seminoma and mixed seminoma/non-seminoma? Int J Androl 29:458–467PubMedCrossRefGoogle Scholar
  21. 21.
    Depue RH, Pike MC, Henderson BE (1983) Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst 71:1151–1155PubMedGoogle Scholar
  22. 22.
    Coupland CA, Forman D, Chilvers CE, Davey G, Pike MC, Oliver RT (2004) Maternal risk factors for testicular cancer: a population-based case-control study (UK). Cancer Causes Control 15:277–283PubMedCrossRefGoogle Scholar
  23. 23.
    Skakkebaek NE, Berthelsen JG, Giwercman A, Müller J (1987) Carcinoma-in situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 10:19–28PubMedCrossRefGoogle Scholar
  24. 24.
    Waheeb R, Hofmann MC (2011) Human spermatogonial stem cells: a possible origin for spermatocytic seminoma. Int J Androl 34:296–305CrossRefGoogle Scholar
  25. 25.
    Altman DG (2000) Statistics with confidence: confidence intervals and statistical guidelines. BMJ Books, London, p xii, 240 sGoogle Scholar
  26. 26.
    Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. I. Age-period and age-cohort models. Stat Med 6:449–467PubMedCrossRefGoogle Scholar
  27. 27.
    Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates. II. Age-period-cohort models. Stat Med 6:469–481PubMedCrossRefGoogle Scholar
  28. 28.
    Trabert B, Stang A, Cook MB, Rusner C, McGlynn KA (2011) Impact of classification of mixed germ-cell tumours on incidence trends of non-seminoma. Int J Androl 34:e274–e277PubMedCrossRefGoogle Scholar
  29. 29.
    Pukkala E (2011) Biobanks and registers in epidemiologic research on cancer. Methods Mol Biol 675:127–164PubMedCrossRefGoogle Scholar
  30. 30.
    Baade P, Carriere P, Fritschi L (2008) Trends in testicular germ cell cancer incidence in Australia. Cancer Causes Control 19:1043–1049PubMedCrossRefGoogle Scholar
  31. 31.
    Walschaerts M, Huyghe E, Muller A, Bachaud JM, Bujan L, Thonneau P (2008) Doubling of testicular cancer incidence rate over the last 20 years in southern France. Cancer Causes Control 19:155–161PubMedCrossRefGoogle Scholar
  32. 32.
    Trama A, Mallone S, Nicolai N et al (2012) Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe. Eur J Cancer 48:159–169PubMedCrossRefGoogle Scholar
  33. 33.
    Perinatal Statistics in the Nordic Countries (2008) Statistical report. National Institute of Health and Welfare, Finland. http://www.stakes.fi/tilastot/tilastotiedotteet/2010/Tr14_10.pdf

Copyright information

© Springer Science+Business Media Dordrecht 2012

Authors and Affiliations

  • Satu-Liisa Pauniaho
    • 1
    • 2
  • Jonna Salonen
    • 3
  • Mika Helminen
    • 4
  • Kim Vettenranta
    • 1
  • Markku Heikinheimo
    • 5
    • 6
  • Oskari Heikinheimo
    • 3
  1. 1.Paediatric Research CentreUniversity of Tampere and Tampere University Hospital, Medical SchoolTampereFinland
  2. 2.Department of SurgeryCentral Hospital of SeinäjokiSeinäjokiFinland
  3. 3.Department of Obstetrics and GynecologyUniversity of Helsinki and Helsinki University Central HospitalHelsinkiFinland
  4. 4.School of Health SciencesUniversity of Tampere and Science Center, Pirkanmaa Hospital District, Tampere University HospitalTampereFinland
  5. 5.Children’s HospitalUniversity of Helsinki, Helsinki University Central HospitalHelsinkiFinland
  6. 6.Department of Pediatrics, School of Medicine, St Louis Children’s HospitalWashington UniversitySt LouisUSA

Personalised recommendations